Tue, Oct 21, 2014, 1:33 PM EDT - U.S. Markets close in 2 hrs 27 mins


% | $
Quotes you view appear here for quick access.

Spectrum Pharmaceuticals, Inc. Message Board

  • dgmc1999 dgmc1999 Feb 22, 2013 5:45 PM Flag

    Folotyn sales

    The acquisition of Allos was 9-6-12.

    For the first month, sales were $3.4 million. A little bit skewed due to 24 day month. Sales were $20.4 million since acquisition.

    I think this might be the diamond in the rough. This could be approx $6 million per month.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Interesting the number of neg vs. positive votes. I expected more negative.

      There is nothing neg or positive about my post. It is relating info from the 10-Q. Which basically is taking facts and displaying them here for people to have more knowledge.

      • 2 Replies to dgmc1999
      • Thanks for this information. I saw the $20.4 million number in the company's press release, stating that this total was for the 4 months since acquisition. That obviously would translate to over $60 million p/a if sales stayed flat. Considering the expanded sales force and the company's focus on these 2 drugs, it would be a surprise if that happened. I'd like to know where you found this information, though. I can't find a 10-Q posted yet for the quarter and if product sales are broken out in the 8-K I can't seem to find the right page. TIA.

      • 27M shorts don't like the current facts. And the facts are that they are screwed. Strong Folotyn sales hurt their argument that SPPI is a one trick pony that is destined for failure. Pretty pathetic that all they can do is hit the thumbs down and watch as time runs out for them.

7.59+0.10(+1.34%)1:33 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.